BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 15555554)

  • 41. OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms.
    Zhang S; Suvannasankha A; Crean CD; White VL; Johnson A; Chen CS; Farag SS
    Clin Cancer Res; 2007 Aug; 13(16):4750-8. PubMed ID: 17699852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia.
    Horton HM; Bernett MJ; Pong E; Peipp M; Karki S; Chu SY; Richards JO; Vostiar I; Joyce PF; Repp R; Desjarlais JR; Zhukovsky EA
    Cancer Res; 2008 Oct; 68(19):8049-57. PubMed ID: 18829563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
    Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
    J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leishmanial lipid suppresses tumor necrosis factor alpha, interleukin-1beta, and nitric oxide production by adherent synovial fluid mononuclear cells in rheumatoid arthritis patients and induces apoptosis through the mitochondrial-mediated pathway.
    Majumdar KN; Banerjee A; Ratha J; Mandal M; Sarkar RN; Saha KD
    Arthritis Rheum; 2008 Mar; 58(3):696-706. PubMed ID: 18311833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells.
    Stang MT; Armstrong MJ; Watson GA; Sung KY; Liu Y; Ren B; Yim JH
    Oncogene; 2007 Sep; 26(44):6420-30. PubMed ID: 17452973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD19-/CD3-bispecific antibody of the BiTE class is far superior to tandem diabody with respect to redirected tumor cell lysis.
    Mølhøj M; Crommer S; Brischwein K; Rau D; Sriskandarajah M; Hoffmann P; Kufer P; Hofmeister R; Baeuerle PA
    Mol Immunol; 2007 Mar; 44(8):1935-43. PubMed ID: 17083975
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer.
    Fu M; Maresh EL; Soslow RA; Alavi M; Mah V; Zhou Q; Iasonos A; Goodglick L; Gordon LK; Braun J; Wadehra M
    Clin Cancer Res; 2010 Aug; 16(15):3954-63. PubMed ID: 20670949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A single-chain Fv diabody against human leukocyte antigen-A molecules specifically induces myeloma cell death in the bone marrow environment.
    Sekimoto E; Ozaki S; Ohshima T; Shibata H; Hashimoto T; Abe M; Kimura N; Hattori K; Kawai S; Kinoshita Y; Yamada-Okabe H; Tsuchiya M; Matsumoto T
    Cancer Res; 2007 Feb; 67(3):1184-92. PubMed ID: 17283154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A monoclonal antibody to the alpha2 domain of murine major histocompatibility complex class I that specifically kills activated lymphocytes and blocks liver damage in the concanavalin A hepatitis model.
    Matsuoka S; Tsurui H; Abe M; Terashima K; Nakamura K; Hamano Y; Ohtsuji M; Honma N; Serizawa I; Ishii Y; Takiguchi M; Hirose S; Shirai T
    J Exp Med; 2003 Aug; 198(3):497-503. PubMed ID: 12885869
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of apoptosis in human lymphocytes by human anti-HLA class I antibodies.
    Daniel D; Opelz G; Mulder A; Süsal C
    Transplantation; 2003 Apr; 75(8):1380-6. PubMed ID: 12717234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T cells armed with anti-CD3 x anti-CD20 bispecific antibody enhance killing of CD20+ malignant B cells and bypass complement-mediated rituximab resistance in vitro.
    Gall JM; Davol PA; Grabert RC; Deaver M; Lum LG
    Exp Hematol; 2005 Apr; 33(4):452-9. PubMed ID: 15781336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 2D7 diabody bound to the alpha2 domain of HLA class I efficiently induces caspase-independent cell death against malignant and activated lymphoid cells.
    Kimura N; Kawai S; Kinoshita Y; Ishiguro T; Azuma Y; Ozaki S; Abe M; Sugimoto M; Hirata Y; Orita T; Okabe H; Matsumoto T; Tsuchiya M
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1201-9. PubMed ID: 15555554
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.